RT Journal Article
SR Electronic
T1 Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.27.20081901
DO 10.1101/2020.04.27.20081901
A1 Burke, Rachel M.
A1 Balter, Sharon
A1 Barnes, Emily
A1 Barry, Vaughn
A1 Bartlett, Karri
A1 Beer, Karlyn D.
A1 Benowitz, Isaac
A1 Biggs, Holly M.
A1 Bruce, Hollianne
A1 Bryant-Genevier, Jonathan
A1 Cates, Jordan
A1 Chatham-Stephens, Kevin
A1 Chea, Nora
A1 Chiou, Howard
A1 Christiansen, Demian
A1 Chu, Victoria
A1 Clark, Shauna
A1 Cody, Sara
A1 Cohen, Max
A1 Conners, Erin E.
A1 Dasari, Vishal
A1 Dawson, Patrick
A1 DeSalvo, Traci
A1 Donahue, Matthew
A1 Dratch, Alissa
A1 Duca, Lindsey
A1 Duchin, Jeffrey
A1 Dyal, Jonathan W.
A1 Feldstein, Leora R.
A1 Fenstersheib, Marty
A1 Fischer, Marc
A1 Fisher, Rebecca
A1 Foo, Chelsea
A1 Freeman-Ponder, Brandi
A1 Fry, Alicia M.
A1 Gant, Jessica
A1 Gautom, Romesh
A1 Ghinai, Isaac
A1 Gounder, Prabhu
A1 Grigg, Cheri T.
A1 Gunzenhauser, Jeffrey
A1 Hall, Aron J.
A1 Han, George S.
A1 Haupt, Thomas
A1 Holshue, Michelle
A1 Hunter, Jennifer
A1 Ibrahim, Mireille B.
A1 Jacobs, Max W.
A1 Jarashow, M. Claire
A1 Joshi, Kiran
A1 Kamali, Talar
A1 Kawakami, Vance
A1 Kim, Moon
A1 Kirking, Hannah
A1 Kita-Yarbro, Amanda
A1 Klos, Rachel
A1 Kobayashi, Miwako
A1 Kocharian, Anna
A1 Lang, Misty
A1 Layden, Jennifer
A1 Leidman, Eva
A1 Lindquist, Scott
A1 Lindstrom, Stephen
A1 Link-Gelles, Ruth
A1 Marlow, Mariel
A1 Mattison, Claire P.
A1 McClung, Nancy
A1 McPherson, Tristan D.
A1 Mello, Lynn
A1 Midgley, Claire M.
A1 Novosad, Shannon
A1 Patel, Megan T.
A1 Pettrone, Kristen
A1 Pillai, Satish K.
A1 Pray, Ian W.
A1 Reese, Heather E.
A1 Rhodes, Heather
A1 Robinson, Susan
A1 Rolfes, Melissa
A1 Routh, Janell
A1 Rubin, Rachel
A1 Rudman, Sarah L.
A1 Russell, Denny
A1 Scott, Sarah
A1 Shetty, Varun
A1 Smith-Jeffcoat, Sarah E.
A1 Soda, Elizabeth A.
A1 Spitters, Chris
A1 Stierman, Bryan
A1 Sunenshine, Rebecca
A1 Terashita, Dawn
A1 Traub, Elizabeth
A1 Vahey, Grace E.
A1 Verani, Jennifer R.
A1 Wallace, Megan
A1 Westercamp, Matthew
A1 Wortham, Jonathan
A1 Xie, Amy
A1 Yousaf, Anna
A1 Zahn, Matthew
YR 2020
UL http://medrxiv.org/content/early/2020/05/03/2020.04.27.20081901.abstract
AB Background Coronavirus disease 2019 (COVID-19), the respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. As part of initial response activities in the United States, enhanced contact investigations were conducted to enable early identification and isolation of additional cases and to learn more about risk factors for transmission.Methods Close contacts of nine early travel-related cases in the United States were identified. Close contacts meeting criteria for active monitoring were followed, and selected individuals were targeted for collection of additional exposure details and respiratory samples. Respiratory samples were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (RT-PCR) at the Centers for Disease Control and Prevention.Results There were 404 close contacts who underwent active monitoring in the response jurisdictions; 338 had at least basic exposure data, of whom 159 had ≥1 set of respiratory samples collected and tested. Across all known close contacts under monitoring, two additional cases were identified; both secondary cases were in spouses of travel-associated case patients. The secondary attack rate among household members, all of whom had ≥1 respiratory sample tested, was 13% (95% CI: 4 – 38%).Conclusions The enhanced contact tracing investigations undertaken around nine early travel-related cases of COVID-19 in the United States identified two cases of secondary transmission, both spouses. Rapid detection and isolation of the travel-associated case patients, enabled by public awareness of COVID-19 among travelers from China, may have mitigated transmission risk among close contacts of these cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was sought or received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be available upon reasonable request.